MIRA
INFORM REPORT
|
Report Date : |
15.05.2007 |
IDENTIFICATION DETAILS
|
Name : |
DEBRA INCORPORATED NIGERIA LIMITED |
|
|
|
|
Registered Office : |
20, Alh. |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
6th February 1989 |
|
|
|
|
Com. Reg. No.: |
RC: 125190 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Subject is into Pharmaceutical
Products services |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Unknown |
IDENTIFICATION
COMPANY NAME: DEBRA INCORPORATED NIGERIA LIMITED
REGISTERED NAME: DEBRA INCORPORATED NIGERIA LIMITED
PREVIOUS NAME: NIL
REGISTERED ADDRESS: 20,
Alh.
Lagos-Nigeria.
HEAD OFFICE ADDRESS: Undetermined
RESIDENT ADDRESS: No.
5B,
TELEPHONE(S): Nil
FAX: Nil
E-MAIL: Nil
WEBSITE: Nil
POSTAL ADDRESS: Nil
Subject is into Pharmaceutical Services
In
Currency: All monetary values in this report are in Nigerian
Naira, the local currency, except otherwise stated. The exchange rate is N130
to 1
SUMMARY
NATURE OF PREMISES: Undetermined
DATE
INCORPORATED: 6th February 1989
YEAR
BEGAN OPERATION: 1989
LEGAL
FORM:
Private
Limited Liability Company (LTD.)
REGISTRATION
NO: RC: 125190
SHARE
CAPITAL: N50, 000 .00
ALLOTTED
SHARE CAPITAL: N50, 000
.00
PAID-UP
CAPITAL N50,
000 .00
AUDITORS: Nil
SOLICITORS: Nil
COMPANY
SECRETARY: Nil
STAFF
STRENGHT: Undetermined
SHAREHOLDERS/DIRECTORS
Bosede O. Debora
20, Alh.
Off
Lagos-Nigeria.
Tope A. Bakare
FH 22,
Rebeca J. Ebun
1,
Ikogosi-Ekiti State-Nigeria
Muyiwa O Josiah
18,
Ado-Ekiti, Ekiti State-Nigeria
Titilayo O. Josiah
Plot 3, Adejuwon Layout
Ondo State-Nigeria
PREVIOUS DIRECTORS
Nil
INCREASE IN SHARE
CAPITAL
Undetermined
MANAGEMENT PROFILE
Undetermined
SUBSIDIARY COMPANIES
Nil
BRANCHES
Nil
BANKER
Nil
PAYMENT REFERENCE
Subject has both local and foreign references
PRODUCT DESCRIPTION
Pharmaceutical Products
PERFORMANCE RANKING
* Quality of Management: Undetermined
* Ethics & Integrity: Undetermined
* Ownership Structure: GOOD
OPERATIONS
Subject is into Pharmaceutical
Products services
BACKGROUND
Undetermined
EXPANSION PLAN
Undetermined
PRINCIPAL ANTECEDENT
Undetermined
PHYSICAL VISIT
Visits were made to the followings:
COMPANY PREMISES
CORPORATE AFFAIRS COMMISSION.
FINANCES
Subject audited accounts were not available as at the time of compiling this report. Therefore, its present financial position could not be ascertained.
DIRECT INTERVIEW
NAME: Nil
POSITION:
Security Guard at the address provide belonging one of the Director
He declined information. He
however promised to pass the questionaire droped with him to the Managing
Director on his return from their office which he refused to disclose the
address during our interview.
INDUSTRIAL OVERVIEW/
OPERATING
ENVIRONMENT
The Pharmaceutical industry in
The government policy in using indigenous contractors to
execute her projects has gone a long way in increasing the capital base,
greater utilization of Nigerian human and material resources in this sector.
CMT REPORT
(Corruption, Money
Laundering &
Terrorism)
Public Notice from various sources including but not limited
to: The Courts, Nigerian Prison Service, Economic & Financial Crimes
Commission (EFCC), National Drug Law Enforcement Agency (NDLEA), National
Agency for Food & Drugs administration and Control (NAFDAC), Independent
Corrupt Practices and Other Related Offences Commission (ICPC) Etc.
No negative information on subject from the above agencies as at the time of compiling this report.
COMPANY LOCATION
The company office location could not ascertain as at the time
of our visit.
OFFICIAL REMARKS
Having carried out all necessary research on subjects, our
investigations revealed that, the company, Debra Incorporated Nigeria Limited
is duly registered in
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)